Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Rebeca Higuera"'
Autor:
Iago Rodríguez‐Lago, Urko Aguirre, Patricia Ramírez de la Piscina, Ana Muñagorri, Eva Zapata, Rebeca Higuera, Isabel Montalvo, Ainara Iriarte, María Fernández‐Calderón, Paz Arreba, Juan Carrascosa, José Luis Cabriada, Manuel Barreiro‐de Acosta
Publikováno v:
United European Gastroenterology Journal. 11:9-18
Previous data support that the inflammatory process underlying ulcerative colitis (UC) and Crohn's disease (CD) can start years before the diagnosis. The aim of this study was to determine if patients with an incidental diagnosis of UC or CD demonstr
Autor:
María Fernández-Calderón, Eva Zapata, Isabel Montalvo, Miguel Muñoz-Navas, Iago Rodríguez-Lago, Rebeca Higuera, Manuel Barreiro-de Acosta, Juan Carrascosa, Ainara Iriarte, Ainara Maiz, Irene Azagra, Paz Arreba, Cynthia Ramírez, Olga Merino, José Luis Cabriada
Publikováno v:
Digestive and Liver Disease. 52:1467-1472
Background The immune response involved in the pathogenesis of Inflammatory Bowel Disease (IBD) may be present years before the diagnosis, but the characteristics of the disease during the preclinical period have been scarcely investigated. Aim To de
Autor:
María Fernández-Calderón, Isabel Montalvo, Iago Rodríguez-Lago, Ainara Iriarte, Isabel Portillo, Olga Merino, Rebeca Higuera, Irene Azagra, Ainara Maiz, Urko Aguirre, Juan Carrascosa, José Luis Cabriada, Eva Zapata, Paz Arreba, Miguel Muñoz-Navas, Manuel Barreiro-de Acosta
Publikováno v:
Clinical Gastroenterology and Hepatology. 16:1459-1466
Background & Aims Inflammatory bowel disease (IBD) is a chronic disease usually diagnosed after the appearance of gastrointestinal symptoms. Little is known about IBD progression during its early and even preclinical phases. We aimed to determine the
Autor:
Laura Gómez-Irwin, Encarnación Fernández, José Luis Cabriada, Rebeca Higuera, Iago Rodríguez-Lago
Publikováno v:
Therapeutic Apheresis and Dialysis. 21:26-30
Biologic anti-tumor necrosis factor (TNF) drugs have demonstrated their efficacy for the treatment of ulcerative colitis. Nevertheless, some patients will not respond to this therapy or will develop loss of response. Leukapheresis is the main non-pha
Autor:
María Fernández-Calderón, Isabel Montalvo, José Luis Cabriada, Miguel Muñoz-Navas, Ainara Maiz, I Rodríguez-Lago, Eva Zapata, Irene Azagra, Rebeca Higuera, Ainara Iriarte, Olga Merino, Paz Arreba, M. Barreiro-de Acosta, Juan Carrascosa
Publikováno v:
Journal of Crohn's and Colitis. 14:S238-S239
Background The diagnosis of ulcerative colitis (UC) is usually established after the development of symptoms, but preclinical disease may be present even years before the final diagnosis. Around 25% of UC patients may show a proximal extension of the
Autor:
Carlos Taxonera, Pilar Martínez-Montiel, Federico Bertoletti, Cristina Alba, Monica Sierra-Ausin, Alicia Algaba, Noemí Manceñido, Óscar Nantes, Saioa Rubio, José Lázaro Pérez-Calle, Marisa Iborra, Marta Maia Bosca-Watts, Rebeca Higuera, David Olivares
Publikováno v:
CURRENT MEDICAL RESEARCH AND OPINION
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Aim: To evaluate outcomes of early dose optimization of golimumab in ulcerative colitis (UC) patients with inadequate response to golimumab induction treatment.Methods: This observational, multicenter, cohort study included patients with moderate-to-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7fe945e75f50126bace2af78370bc37
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3844
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3844
Autor:
Paz Arreba, I Rodríguez-Lago, Rebeca Higuera, Ainara Iriarte, José Luis Cabriada, María Fernández-Calderón, M. Barreiro-de Acosta, Irene Azagra, Isabel Montalvo, Juan Carrascosa, Ainara Maiz, Eva Zapata, Miguel Muñoz-Navas, Olga Merino
Publikováno v:
Journal of Crohn's and Colitis. 14:S218-S218
Background The diagnosis of inflammatory bowel disease (IBD) is usually established after the development of symptoms, but preclinical disease may be present years before the final diagnosis. Recently, histology has become one of the main outcomes of
Autor:
Juan Antonio Arévalo, Rebeca Higuera, Iago Rodríguez, Sylvia Ibáñez, Jone Ortiz de Zarate, Olga Merino, Laura Gomez, Cristina Rodríguez, Patricia Ramirez de la Piscina, José Luis Cabriada, Carmen Muñoz-Villafranca, Antonio Bernal, Maria Ogueta, Ana Muñagorri, Paz Arreba, Óscar Nantes
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 50(8)
Background Adalimumab is the second tumour necrosis factor antagonist (anti-TNF) adopted for the treatment of ulcerative colitis. Clinical data from naive patients are scarce. Aim Examine the response to adalimumab in TNF-antagonist-naive patients. M
Publikováno v:
Open Journal of Gastroenterology. :208-215
Objective: The aim of this study is to evaluate the colonic cleansing preparation and colorectal cancer screening results in Sestao (Bilbao); and to verify the safety of endoscopist-controlled sedation. Materials and methods: A retrospective observat
Publikováno v:
Gastroenterología y Hepatología. 31:497-499
Eosinophilic esophagitis is a rare, recently discovered disease, characterized by esophageal symptoms, such as dysphagia and food impaction, associated with dense eosinophilia on endoscopic biopsy of the esophagus. Other entities such as gastroesopha